# DAPAgliflozin for Renal Protection in Heart Transplant Recipients

> clinical trial · VERIFIED · 2026-07-01

Status: ACTIVE_NOT_RECRUITING · Sponsor: Oslo University Hospital · Condition: Heart Transplant Failure

- Company: Oslo University Hospital
- Sector: cardiovascular
- Primary source: https://clinicaltrials.gov/study/NCT05321706

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.